Table 6.

Correlations between and among serum concentrations of ΒΟΗΒ, carnitine, C16, and C14 by group

Group	Variable 1	Variable 2	Spearman r	P (two tailed)
Control subjects	C16	C2	0.595	0.012
T2D patients with hyperglycemia	BOHB	Carnitine	0.06	0.82
		C16	0.21	0.45
		C14	0.36	0.19
	C16	C2	0.489	0.025
KPD patients with DKA	BOHB	Carnitine	−0.279	0.05
		C16	0.464	0.001
		C14	0.348	0.017
	C16	C2	0.489	0.025
T1D patients with DKA	BOHB	Carnitine	−0.551	0.026
		C16	0.398	0.09
		C14	0.315	0.18
	C16	C2	0.533	0.013